Chimerix eyes $100 million stock offering as share price leaps

A Durham biopharma is aiming to raise around $100 million through a stock offering – and the news brought a boost to the company's stock price.
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Source Type: news